Subayno, April Kate .

HRN: 25-46-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2026
CEFUROXIME 750MG (VIAL)
05/30/2026
06/06/2026
IV
750 Mg
Q 8
T/C UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines